Skip to main content
Premium Trial:

Request an Annual Quote

What to Do About Review

At Open …, Glyn Moody recently blogged that peer review, at least as it is done now, is not necessary. Moody writes that the system was set up in a time when opportunities to publish were scarce and "needed husbanding." Today though, Moody says that with the Internet, there are a plethora of publishing opportunities and "there are all kinds of systems that allow any scientist — or even the general public — to rate content and to vote it up towards a wider audience."

Deepak Singh at business|bytes|genes|molecules says he disagrees even though he is "not a huge fan of the current peer-review system." Singh writes that peer review can be a source of advice that improves the quality of science. He does, however, say that what goes through the peer-review process should be changed. "To put this another way, with peer-review we should be focussing on a subset of what we publish today, while the rest goes into blogs, Nature Precedings, self-published articles, etc," he writes.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.